(ALK-B) ALK-Abelló - Performance 15.3% in 12m
Compare ALK-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
32.23%
#21 in Group
Rel. Strength
70.81%
#2231 in Universe
Total Return 12m
15.28%
#35 in Group
Total Return 5y
75.61%
#25 in Group
P/E 39.1
74th Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -0.29%
78th Percentile in Group
12m Total Return: ALK-B (15.3%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ALK-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALK-B
Total Return (including Dividends) | ALK-B | XBI | S&P 500 |
---|---|---|---|
1 Month | -6.49% | -5.85% | -3.01% |
3 Months | -13.28% | -11.95% | -3.15% |
12 Months | 15.28% | -11.00% | 10.19% |
5 Years | 75.61% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | ALK-B | XBI | S&P 500 |
1 Month | -8.70% | -59.8% | -5.5% |
3 Months | -55.3% | -70.5% | -58.4% |
12 Months | 18.7% | -6.9% | 84.1% |
5 Years | 26.3% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #81 | -0.69% | -3.60% |
3 Month | #60 | -1.51% | -10.5% |
12 Month | #35 | 29.5% | 4.62% |
5 Years | #28 | 74.5% | -23.4% |
FAQs
Does ALK-B ALK-Abelló outperforms the market?
Yes,
over the last 12 months ALK-B made 15.28%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ALK-B made -13.28%, while XBI made -11.95%.
Over the last 3 months ALK-B made -13.28%, while XBI made -11.95%.
Performance Comparison ALK-B vs Indeces and Sectors
ALK-B vs. Indices ALK-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.89% | -3.48% | -16.8% | 5.09% |
US NASDAQ 100 | QQQ | 3.87% | -2.43% | -16.1% | 6.68% |
US Dow Jones Industrial 30 | DIA | 2.69% | -4.35% | -17.7% | 5.77% |
German DAX 40 | DAX | 4.19% | -3.11% | -33.6% | -6.41% |
Shanghai Shenzhen CSI 300 | CSI 300 | 3.18% | -6.72% | -1.59% | 6.16% |
Hongkong Hang Seng | HSI | 0.92% | -9.26% | -7.60% | -2.05% |
India NIFTY 50 | INDA | 1.86% | -14.4% | -6.47% | 14.6% |
Brasil Bovespa | EWZ | 2.78% | -14.8% | -8.82% | 27.0% |
ALK-B vs. Sectors ALK-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.43% | -2.68% | -24.9% | -3.93% |
Consumer Discretionary | XLY | 2.13% | -2.66% | -20.2% | 1.22% |
Consumer Staples | XLP | 0.10% | -4.65% | -17.7% | 4.25% |
Energy | XLE | 1.80% | -14.5% | -22.4% | 14.5% |
Financial | XLF | 2.41% | -3.79% | -29.0% | -6.97% |
Health Care | XLV | 2.47% | -3.33% | -12.1% | 13.6% |
Industrial | XLI | 2.58% | -5.80% | -16.1% | 6.75% |
Materials | XLB | 1.79% | -7.0% | -8.71% | 19.2% |
Real Estate | XLRE | 0.85% | -3.80% | -13.7% | 1.92% |
Technology | XLK | 4.02% | -2.48% | -11.7% | 13.3% |
Utilities | XLU | -0.40% | -7.31% | -15.9% | -9.95% |
Aerospace & Defense | XAR | 3.49% | -7.77% | -20.7% | -5.65% |
Biotech | XBI | 7.45% | -0.64% | 0.88% | 26.3% |
Homebuilder | XHB | 2.39% | -6.64% | 2.56% | 23.0% |
Retail | XRT | 0.59% | -5.99% | -12.7% | 20.1% |